Beyond Meat, Spring Valley Acquisition, Scienture, Veritex, and Ventyx Biosciences are the five Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of publicly traded companies with relatively small market capitalizations—typically roughly between $300 million and $2 billion, though exact cutoffs vary by index and provider. They often offer higher growth potential but also greater volatility and liquidity risk than large-cap stocks, making them a higher-risk, higher-reward segment for investors. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.
Beyond Meat (BYND)
Beyond Meat, Inc., a plant-based meat company, develops, manufactures, markets, and sells plant-based meat products in the United States and internationally. The company sells a range of plant-based meat products across the platforms of beef, pork, and poultry. It sells its products through grocery, mass merchandiser, club stores, and natural retailer channels, as well as various food-away-from-home channels, including restaurants, foodservice outlets, and schools.
Read Our Latest Research Report on BYND
Spring Valley Acquisition (SV)
Read Our Latest Research Report on SV
Scienture (SCNX)
Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.
Read Our Latest Research Report on SCNX
Veritex (VBTX)
Veritex Holdings, Inc. operates as the bank holding company for Veritex Community Bank that provides various commercial banking products and services to small and medium-sized businesses, and professionals. The company accepts deposit products include demand, savings, money market, and time accounts.
Read Our Latest Research Report on VBTX
Ventyx Biosciences (VTYX)
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease.
Read Our Latest Research Report on VTYX
Recommended Stories
Before you consider Beyond Meat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Beyond Meat wasn't on the list.
While Beyond Meat currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for November 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.